on 'API'

1-5 of 5 < first | prev | next | last >
  • The evolution of API route decisions

    How advancements in biocatalytic capabilities have added to the API development and manufacturing toolbox

    Tonia Becker Sr. Consultant, Synthetic Biology, Life Sciences and Chemicals, Haig Barrett
  • Sustainable Drugs From the Start

    China-based Porton Pharma’s partnership with Codexis will bring new and improved manufacturing routes for APIs

    Karen Langhauser, Chief Content Director
  • Analyzing for Elemental Impurities

    Understanding new guidance from the USP

    Nikki Schopp, Assistant Manager, Analytical Laboratory Services, SGS Life Sciences
  • API Sourcing: Your Questions Answered

    Sourcing high quality APIs in a cost and time efficient manner requires a detailed understanding of manufacturing regulations and global supply chains

    Jan Batka, API sales director, Saneca Pharma
1-5 of 5 < first | prev | next | last >